Hemophilia RM Emails

• n7-gt-and-factor-vii-ii-ches  
• n7-gt-and-factor-vii-ii-ches.html
• US25NSVN00035   September 2025

• Last updated: 2025-11-25 22:27:25

• Version: 7

• 🩸Questions about bleeds or treatment? Start here.

• ✨Treatment insights. Real support. All in one place.

• 🙋 Let’s talk about managing bleeds—together.

• 💛 There’s more support for bleeding disorders than you might think.

• Why do so many people trust this bleed control option?

• Seeking support for Glanzmann’s thrombasthenia when platelets don’t work or Factor 7 deficiency?

• 👋 Hello there, have you met your Community Liaison yet?

• Get 1-1 support on taking charge of your care.
• Learn who can provide 1-1 support.
• Take the next step. Speak with a bleeding disorders expert.
• Connect with a Community Liaison today.
• See what’s possible with decades of research and innovation.
• Talk to a rare bleeding disorders expert.
• Find resources, info on local events, and more!

Handoff: September 2025

• n7-gt-and-factor-vii-rbcl-ches  
• n7-gt-and-factor-vii-rbcl-ches.html
• US25NSVN00046   September 2025

• Last updated: 2025-12-11 18:34:36

• Version: 5

• 🩸 Looking for info about your rare bleeding disorder?

• You don’t have to navigate rare bleeding disorders alone.

• 👋 Where are you in your rare bleeding disorder journey?

• Rare bleeding disorders can feel overwhelming at times.

• Searching for fast bleed control when you need it?

• Interested in resources for Glanzmann's Thrombasthenia or Factor 7 Deficiency?

• Our community team is here to help.
• Get one-on-one support and guidance.
• Connect with our Community Liaisons for 1-1 support.
• Talk to someone who understands what you’re going through.
• Take the next step and talk to a Community Liaison.
• Connect with your local Community Liaison.

Handoff: September 2025

• n7-gt-and-factor-vii-rbcl  
• n7-gt-and-factor-vii-rbcl.html
• US25NSVN00046   September 2025

• Last updated: 2025-12-11 18:32:01

• Version: 12

• 🩸 Looking for info about your rare bleeding disorder?

• You don’t have to navigate rare bleeding disorders alone.

• 👋 Where are you in your rare bleeding disorder journey?

• Rare bleeding disorders can feel overwhelming at times.

• Searching for fast bleed control when you need it?

• Interested in resources for Glanzmann's Thrombasthenia or Factor 7 Deficiency?

• Our community team is here to help.
• Get one-on-one support and guidance.
• Connect with our Community Liaisons for 1-1 support.
• Talk to someone who understands what you’re going through.
• Take the next step and talk to a Community Liaison.
• Connect with your local Community Liaison.

Handoff: September 2025

• n7-gt-and-factor-vii-ii  
• n7-gt-and-factor-vii-ii.html
• US25NSVN00035   September 2025

• Last updated: 2025-12-10 23:13:27

• Version: 5

• 🩸Questions about bleeds or treatment? Start here.

• ✨Treatment insights. Real support. All in one place.

• 🙋 Let’s talk about managing bleeds—together.

• 💛 There’s more support for bleeding disorders than you might think.

• Why do so many people trust this bleed control option?

• Seeking support for Glanzmann’s thrombasthenia when platelets don’t work or Factor 7 deficiency?

• 👋 Hello there, have you met your Community Liaison yet?

• Get 1-1 support on taking charge of your care.
• Learn who can provide 1-1 support.
• Take the next step. Speak with a bleeding disorders expert.
• Connect with a Community Liaison today.
• See what’s possible with decades of research and innovation.
• Talk to a rare bleeding disorders expert.
• Find resources, info on local events, and more!

Handoff: September 2025

• n7-gt-and-factor-vii  
• n7-gt-and-factor-vii.html
• US25NSVN00046   September 2025

• Last updated: 2025-09-19 17:30:20

• Version: 7

• 🩸 Looking for info about your rare bleeding disorder?

• You don’t have to navigate rare bleeding disorders alone.

• 👋 Where are you in your rare bleeding disorder journey?

• Rare bleeding disorders can feel overwhelming at times.

• Searching for fast bleed control when you need it?

• Interested in resources for Glanzmann's Thrombasthenia or Factor 7 Deficiency?

• Our community team is here to help.
• Get one-on-one support and guidance.
• Connect with our Community Liaisons for 1-1 support.
• Talk to someone who understands what you’re going through.
• Take the next step and talk to a Community Liaison.
• Connect with your local Community Liaison.

Handoff: September 2025

• n7-hsp-feiba-defense-pharmacy (Pharmacy Version)
• n7-hsp-feiba-defense-pharmacy.html
• US24NSVN00078   December 2024

• Last updated: 2025-01-14 16:12:38

• Version: 1

• A1 Let’s see the key differences between rFVIIa and pd-aPCC products

• A2 Have you seen the key differences between rFVIIa and pd-aPCC products?

• B1 Have you compared infusion times of bleeding disorders treatments?

• B2 How important are fast infusions for your hospital?

• C1 Could you help more patients with this single treatment?

• A1 Review the main components of each treatment.
• A2 Review the main components of each treatment.
• B1 Explore differences between products.
• B2 Explore differences between products.
• C1 Learn the differences between this rFVIIa and pd-aPCC.

Handoff: January 14, 2025

• n7-hsp-feiba-defense-hospital (Hospital Version)
• n7-hsp-feiba-defense-hospital.html
• US24NSVN00078   December 2024

• Last updated: 2025-01-13 23:43:27

• Version: 5

• A1 See key differences between rFVIIa and pd-aPCC products →

• A2 Have you seen the key differences between rFVIIa and pd-aPCC products?

• B1 Have you compared infusion times of bleeding disorders treatments?

• B2 How many components are in your patients’ bleeding disorder treatment?

• C1 How important is a fast infusion for your patients?

• A1 Learn the main components of each treatment.
• A2 Learn the main components of each treatment.
• B1 Learn the differences between products.
• B2 Learn the differences between products.
• C1 Learn the differences between rFVIIa and pd-aPCC products.

Handoff: January 12, 2025

• n7-patient-track-record (Preliminary handoff. Waiting on final GA tagging)
• n7-patient-track-record.html
• US24NSVN00057   October 2024

• Last updated: 2025-01-15 00:43:06

• Version: 4

• A1 We’re here to support you

• A2 We’re dedicated to your treatment needs

• B1 Shining a spotlight on hemophilia B with inhibitors

• B2 Hear from the hemophilia B with inhibitors community

• A1 See how to reach out for help or more product information.
• A2 Discover ways to connect for support and guidance.
• B1 Listen to one patient’s journey with a rare diagnosis.
• B2 One patient shares his experience and treatment journey.

Handoff: October 2024

(Preliminary handoff. Waiting on final GA tagging)

• n7-hcp-gt-journey-identify-channel-partner (version for Channel Partner: Medscape)
• n7-hcp-gt-journey-identify.html
• US22NSVN00060   October 2022

• Last updated: 2024-12-03 14:30:27

• Version: 1

• A1 (Name:) Curated educational resources for you

• A2 Tools and resources for identifying Glanzmann's Thrombasthenia

• B1 Identifying this rare bleeding disorder presents multiple challenges

• B2 (Name:) Did you know this rare bleeding disorder is often misdiagnosed?

• C1 Could one of your patients have this often misdiagnosed rare bleeding disorder?

• A1 Are you prepared to diagnose this rare bleeding disorder?
• A2 Are you prepared to diagnose this rare bleeding disorder?
• B1 Explore Glanzmann's Thrombasthenia educational resources.
• B2 Explore Glanzmann's Thrombasthenia educational resources.
• C2 Learn how to spot the signs of Glanzmann's Thrombasthenia.

Handoff: December 03, 2024

(Version for channel partner deployment: Medscape)

• n7-patient-promotional-hem-b-inhibitors-rbcl-update
• n7-patient-promotional-hem-b-inhibitors-rbcl-update.html
• US24NSVN00006   April 2024

• Last updated: 2024-05-23 21:07:34

• Version: 3

• (A) [FirstName], your experiences living with hemophilia B with inhibitors are different than others

• (B) [FirstName], you deserve more than just a treatment

• (C) Novo Nordisk has resources available just for people living with hemophilia B with inhibitors

• (D) Connect with resources curated for the hemophilia B with inhibitors community

• (A) Novo Nordisk has resources available just for you.
• (B) Connect to resources created especially for you and your hemophilia B with inhibitors community.
• (C) Get the support you deserve.
• (D) Novo Nordisk has resources just for you.

Handoff: May 23, 2024

• n7-hcp-urgency-to-treat-2023
• n7-hcp-urgency-to-treat-2023.html
• US23NSVN00041   September 2023

• Last updated: 2023-09-12 15:44:15

• Version: 4

• A1 When do acute bleeds require urgent action?

• A2 How urgently should you treat acute bleeds?

• B1 Breakthrough bleeds happen. Make sure your patients are prepared.

• B2 Are your patients prepared for breakthrough bleeds?

• A1 Explore real-world data.
• A2 Explore real-world data.
• B1 See why treating quickly makes a difference.
• B2 See why treating quickly makes a difference.

Handoff: September 2023

• n7-pt-gt-CHES Updated Version for CHES
• n7-pt-gt-CHES.html
• US19NSVN00138   September 2020

• Last updated: 2023-7-11 10:30:26

• Version: 4

• A1 Want to take a short quiz about life with Glanzmann’s thrombasthenia?

• A2 Who’s the expert on life with Glanzmann’s thrombasthenia?

• B1 A short quiz about life with Glanzmann’s thrombasthenia

• B2 5 questions about life with Glanzmann’s thrombasthenia

• A1 Start by answering this true or false question.
• A2 Answer some true or false questions about possible symptoms.
• B1 Which of these questions are true or false?
• B2 Take this short true or false quiz about treating related symptoms.

Handoff: July 11, 2023

(Updated Version for CHES with updated GA Tagging, footer copy updates, replaced footer logo, removed NovoSecure Slab section, and other misc. QA fixes/updates)

• n7-patient-track-record-CHES Version for CHES
• n7-patient-track-record-CHES.html
• US20NSVN00094   October 2020

• Last updated: 2023-07-07 11:30:05

• Version: 2

• A1 We’re here to support you

• A2 We’re dedicated to your treatment needs

• B1 Shining a spotlight on hemophilia B with inhibitors

• B2 Hear from the hemophilia B with inhibitors community

• A1 See how to reach out for help or more product information.
• A2 Discover ways to connect for support and guidance.
• B1 Listen to one patient’s journey with a rare diagnosis.
• B2 One patient shares his experience and treatment journey.

Handoff: July 07, 2023

(Version for CHES with updated GA Tagging, footer and other misc. updates)

• n7-patient-seventfact-chapter-CHBwI-audience-CHES (Version for CHES)
• n7-patient-seventfact-chapter-CHBwI-audience-CHES.html
• US20NSVN00137   November 2020

• Last updated: 2023-06-28 17:28:28

• Version: 2

• A1 See why we’re trusted by people like you

• A2 👀 See why we’re trusted by people like you

• B1 4 great reasons to feel good about this therapy

• B2 A few great reasons to feel good about this therapy

• A1 Decades of experience, strong patient support, and more.
• A2 Decades of experience, strong patient support, and more.
• B1 See how our experience supports you.
• B2 See how our experience supports you.

Handoff: June 28, 2023

(Updated GA tags, NovoCare, and other misc updates)

• n7-patient-connect-with-hcl
• n7-patient-connect-with-hcl.html
• US21NSVN00088   January 2022

• Last updated: 2023-03-17 17:01:14

• Version: 2

• A1 Get the personalized support you deserve.

• A2 [NAME], have you met your HCL?

• B1 Stay connected to the bleeding disorders community.

• B2 Looking for new resources, [NAME]?

• A1 Our team can help, [NAME].
• A2 Your Hemophilia Community Liaison is here for you.
• B1 Our team is here to support you, [NAME].
• B2 Meet your local Hemophilia Community Liaison.

Handoff: January 2022

(N7 Patient Journey CHAwI)

• n7-patient-hem-a-standard-of-care-refresh
• n7-patient-hem-a-standard-of-care-refresh.html
• US22NSVN00012   May 2022

• Last updated: 2023-03-17 15:17:00

• Version: 4

• A1 [FirstName], are you prepared when a bleed happens unexpectedly?

• A2 [FirstName], bleeds should be treated urgently

• B1 [FirstName], are you using a trusted treatment option when a bleed happens?

• B2 If you live with hemophilia with inhibitors, you need fast bleed control

• (Alt Subject Line 1) How can people with hemophilia with inhibitors quickly resolve unexpected bleeds?

• A1 Discover a treatment option for sudden bleeds.
• A2 See why people with hemophilia with inhibitors should consider this treatment option.
• B1 Consider an option that comes with an established safety profile.
• B2 This recombinant treatment option has been trusted for more than 30 years.
• (Alt Preheader 1) Consider the established safety profile of this recombinant treatment.

Handoff: May 2022

(N7 Patient Journey CHAwI)

• n7-patient-seventfact
• n7-patient-seventfact.html
• US20NSVN00137   November 2020

• Last updated: 2023-03-16 20:57:34

• Version: 15

• A1 See why we’re trusted by people like you

• A2 👀 See why we’re trusted by people like you

• B1 Here are some reasons to feel good about this therapy

• B2 A few great reasons to feel good about this therapy

• A1 Decades of experience, strong patient support, and more.
• A2 Decades of experience, strong patient support, and more.
• B1 See how our experience supports you.
• B2 See how our experience supports you.

Handoff: November 2020

(N7 Patient Journey CHAwI)

• n7-pt-gt-email-1
• n7-pt-gt-email-1.html
• US19NSVN00138   September 2020

• Last updated: 2023-03-13 21:38:44

• Version: 8

• A1 Want to take a short quiz about life with Glanzmann’s thrombasthenia?

• A2 Who’s the expert on life with Glanzmann’s thrombasthenia?

• B1 A short quiz about life with Glanzmann’s thrombasthenia

• B2 5 questions about life with Glanzmann’s thrombasthenia

• A1 Start by answering this true or false question.
• A2 Answer some true or false questions about possible symptoms.
• B1 Which of these questions are true or false?
• [object Object]

Handoff: September 2020

(N7 Patient Journey GT)

• n7-pt-talk-to-your-doctor
• n7-pt-talk-to-your-doctor.html
• US19NSVN00139   October 2020
• Email on Acid

• Last updated: 2023-03-09 20:51:29

• Version: 15

• A1 What GT treatment questions should you ask your doctor?

• A2 Make the most of your next doctor’s appointment

• B1 Is your treatment for Glanzmann’s thrombasthenia doing the job?

• B2 A doctor discussion guide specific to Glanzmann’s thrombasthenia

• A1 Our discussion guide for Glanzmann’s thrombasthenia can help.
• A2 Download our discussion guide for Glanzmann’s thrombasthenia.
• B1 If you haven’t taken this quiz, you may be missing answers.
• B2 Download the guide to make the most of your next visit

Handoff: October 2020

(N7 Patient Journey GT)

• n7-patient-sevenfact-defensive-messaging
• n7-patient-sevenfact-defensive-messaging.html
• US21NSVN00090   December 2021

• Last updated: 2023-03-06 18:25:55

• Version: 1

• A1 Comparing rFVIIa treatments?

• A2 Looking for an established treatment?

• B1 Real patients, real stories

• B2 What's Miguel’s rFVIIa choice?

• C1 Only one rFVIIa has 30 years of experience and trust

• C2 Which rFVIIa comes with 30 years of experience and trust?

• D1 Choosing an rFVIIa treatment?

• D2 Get the facts about an rFVIIa treatment choice

• A1 Follow the facts.
• A2 One rFVIIa comes with 30 years of experience.
• B1 What does Miguel expect from his rFVIIa treatment?
• B2 Get the facts about an rFVIIa with 30 years of experience.
• C1 Get the facts about treatment options.
• C2 Get the facts about treatment options.
• D1 Find out why other patients choose this one.
• D2 Learn how other patients made their decision.

Handoff: December 2021

(N7 Patient Journey CHBwI)

• n7-hsp-rare-bleeding-disorders-education
• n7-hsp-rare-bleeding-disorders-education.html
• US22NSVN00038   July 2022

• Last updated: 2023-02-07 14:26:12

• Version: 4

• A1 Explore resources for treating hemophilia and other rare bleeding disorders

• A1 Take a look around the novoMEDLINK™ experience.

Handoff: July 2022

(Outlook for Mac table align fix)

• n7-global-campaign-hospital-series (Hospital Version)
• n7-global-campaign-hospital-series.html
• US22NSVN00058   August 2022

• Last updated: 2022-02-08 11:25:16

• Version: 6

• A1 30+ years of effective bleed control

• A1 See why patients and professionals rely on this rFVIIa treatment.

Handoff: August 2022

(Outlook for Mac table align fix)

• n7-global-campaign-pharmacy-series (Pharmacy Version)
• n7-global-campaign-pharmacy-series.html
• US22NSVN00059   August 2022

• Last updated: 2023-02-08 11:50:10

• Version: 5

• A1 30+ years of effective bleed control

• A1 See why patients and professionals rely on this rFVIIa treatment.

Handoff: August 2022

(Outlook for Mac table align fix)

• n7-hcp-sevenfact-defense
• n7-hcp-sevenfact-defense.html
• US21NSVN00105   December 2021

• Last updated: 2023-02-08 13:35:24

• Version: 11

• A1 Looking for an established treatment for your patients with bleeding disorders?

• A2 Trust comes from experience when treating patients with rare bleeding disorders

• B1 Consider prescribing an established rFVIIa for your patients

• B2 No two rFVIIa products are the same

• C1 How do these two rFVIIa products stack up?

• C2 Which rFVIIa do you prescribe for rare bleeding disorders?

• A1 See how these rFVIIa treatments stack up.
• A2 See which rFVIIa is right for your patients.
• B1 See the clinical data.
• B2 Explore the clinical data for this rFVIIa.
• C1 See which is right for your patients.
• C2 See which is right for your patients.

Handoff: December 2022

(Outlook for Mac table align fix)

• n7-hsp-CFVIId (HSP Hospital Version)
• n7-hsp-CFVIId.html
• US22NSVN00068   November 2022

• Last updated: 2023-02-09 10:44:17

• Version: 6

• HCP Subject Lines
• A1: Are you prepared to help your patients with CFVIId?
• A2: Are you prepared? How to treat patients with CFVIId
• B1: Why early treatment for CFVIId is important
• B2: CFVIId: early treatment is important
• HSP Subject Lines
• A1: How to prepare your hospital team for patients with CFVIId
• A2: Is your hospital team prepared? Treating patients with CFVIId
• B1: Why preparing to treat CFVIId urgently is important for your hospital team
• B2: CFVIId? Preparing your hospital team to urgently treat it is important
• HCP Phrasee Subject Lines
• 1: **For HCPs ** Timely intervention is important for patients with CFVIId.
• 2: Attention, health care providers: discover the importance of early treatment for CFVIId
• 3: Early CFVIId treatment = essential.
• 4: [[ CFVIId ]] Identification and treatment is best done early
• 5: 📩 Your CFVIId informational email | Top reasons why treatment should start early
• 6: Are you prepared to treat this bleeding disorder?
• 7: Early intervention for CFVIId is VITAL >>>
• 8: Click here to learn more about early treatment for CFVIId
• 9: Have patients with CFVIId? Here's why early treatment is important
• HSP Phrasee Subject Lines
• 1: Prepared to treat patients with CFVIId? Here's what you should know
• 2: (( Stay up to date )) Be sure that your hospital team has everything it needs
• 3: Health care providers, this is for YOU - learn more about treating patients with CFVIId
• 4: Does your hospital team take care of patients with CFVIId? >> You should check this out...
• 5: Here's some information on treating patients with CFVIId
• 6: This info could be useful for your hospital team ▶
• 7: Get your hospital team ready for treating patients with CFVIId
• 8: Get the info you need to care for patients with CFVIId - we think this may interest you
• 9: 👋 Don't miss this - make sure you have all the necessary information
• 10: For you and your hospital team: read more about treating patients with CFVIId

• HCP Preheaders
• A1: See why early treatment is crucial.
• A2: See why early treatment is crucial.
• B1: Discover a product that offers bleed control for patients with CFVIId.
• B2: Discover a product that offers bleed control for patients with CFVIId.
• HSP Preheaders
• A1: Learn about the crucial need for early treatment.
• A2: Learn about the crucial need for early treatment.
• B1: Discover a product that offers bleed control for patients with CFVIId.
• B2: Discover a product that offers bleed control for patients with CFVIId.

Handoff: November 2022

(Outlook for Mac table align fix)

• n7-hcp-CFVIId (HCP Healthcare Version)
• n7-hcp-CFVIId.html
• US22NSVN00068   November 2022

• Last updated: 2023-02-08 14:53:17

• Version: 6

• HCP Subject Lines
• A1: Are you prepared to help your patients with CFVIId?
• A2: Are you prepared? How to treat patients with CFVIId
• B1: Why early treatment for CFVIId is important
• B2: CFVIId: early treatment is important
• HSP Subject Lines
• A1: How to prepare your hospital team for patients with CFVIId
• A2: Is your hospital team prepared? Treating patients with CFVIId
• B1: Why preparing to treat CFVIId urgently is important for your hospital team
• B2: CFVIId? Preparing your hospital team to urgently treat it is important
• HCP Phrasee Subject Lines
• 1: **For HCPs ** Timely intervention is important for patients with CFVIId.
• 2: Attention, health care providers: discover the importance of early treatment for CFVIId
• 3: Early CFVIId treatment = essential.
• 4: [[ CFVIId ]] Identification and treatment is best done early
• 5: 📩 Your CFVIId informational email | Top reasons why treatment should start early
• 6: Are you prepared to treat this bleeding disorder?
• 7: Early intervention for CFVIId is VITAL >>>
• 8: Click here to learn more about early treatment for CFVIId
• 9: Have patients with CFVIId? Here's why early treatment is important
• HSP Phrasee Subject Lines
• 1: Prepared to treat patients with CFVIId? Here's what you should know
• 2: (( Stay up to date )) Be sure that your hospital team has everything it needs
• 3: Health care providers, this is for YOU - learn more about treating patients with CFVIId
• 4: Does your hospital team take care of patients with CFVIId? >> You should check this out...
• 5: Here's some information on treating patients with CFVIId
• 6: This info could be useful for your hospital team ▶
• 7: Get your hospital team ready for treating patients with CFVIId
• 8: Get the info you need to care for patients with CFVIId - we think this may interest you
• 9: 👋 Don't miss this - make sure you have all the necessary information
• 10: For you and your hospital team: read more about treating patients with CFVIId

• HCP Preheaders
• A1: See why early treatment is crucial.
• A2: See why early treatment is crucial.
• B1: Discover a product that offers bleed control for patients with CFVIId.
• B2: Discover a product that offers bleed control for patients with CFVIId.
• HSP Preheaders
• A1: Learn about the crucial need for early treatment.
• A2: Learn about the crucial need for early treatment.
• B1: Discover a product that offers bleed control for patients with CFVIId.
• B2: Discover a product that offers bleed control for patients with CFVIId.

Handoff: November 2022

(Outlook for Mac table align fix)

• n7-hsp-chwi-overview-refresh
• n7-hsp-chwi-overview-refresh.html
• US22NSVN00039   August 2022

• Last updated: 2023-02-09 13:21:52

• Version: 5

• A1 CHwI patients can experience breakthrough bleeds

• A1 Treat them quickly with this rFVIIa

Handoff: August 2022

(Outlook for Mac table align fix)

• n7-hsp-gt-overview-refresh
• n7-hsp-gt-overview-refresh.html
• US22NSVN00056   September 2022

• Last updated: 2023-02-09 13:54:14

• Version: 4

• A1 Looking to learn more about diagnosing Glanzmann’s thrombasthenia?

• A2 Diagnostic and treatment considerations for Glanzmann’s thrombasthenia

• B1 Is your hospital prepared to treat Glanzmann’s thrombasthenia patients?

• B2 Make sure your hospital is prepared to treat Glanzmann’s thrombasthenia patients

• C1 Explore diagnostic resources for Glanzmann’s thrombasthenia

• C2 Is your hospital prepared to diagnose and treat rare bleeding disorders?

• D1 Have you encountered this one-in-a-million bleeding disorder?

• D2 Can you spot the signs of this rare bleeding disorder?

• A1 Resources and data curated for you.
• A2 Resources and data curated for you.
• B1 Consider this treatment option for patients with refractoriness to platelets.
• B2 Consider this treatment option for patients with refractoriness to platelets.
• C1 Learn more about a recombinant treatment option.
• C2 Learn more about a recombinant treatment option for Glanzmann’s thrombasthenia.
• D1 Diagnosing this rare disease can be challenging.
• D2 Diagnosing this rare disease can be challenging.

Handoff: September 2022

(Outlook for Mac table align fix)

• n7-hsp-ah-overview
• n7-hsp-ah-overview.html
• US22NSVN00072   November 2022

• Last updated: 2023-01-30 19:52:16

• Version: 6

• A1 Explore acquired hemophilia and the importance of early diagnosis and treatment
• A2 Acquired hemophilia: the importance of early diagnosis
• B1 See why a delayed diagnosis of acquired hemophilia can put patients at risk
• B2 Your patients with acquired hemophilia: see the dangers of a delayed diagnosis

• A1 Get the facts about treatment.
• A2 Get the facts about treatment.
• B1 Learn more about a first-line treatment.
• B2 Learn more about a first-line treatment.

Handoff: November 2022

(Added padding fix to "Key Facts..." section)

• n7-hsp-storage-and-infusion-refresh
• n7-hsp-storage-and-infusion-refresh.html
• US22NSVN00055   September 2022

• Last updated: 2022-12-14 10:15:32

• Version: 6

• A1 Your hospital team relies on you. Be prepared with this rFVIIa.

• A2 Prepare your hospital team with this rFVIIa

• B1 Tools for your pharmacy team

• B2 Curated for you: try this dosing calculator

• C1 Tools for your hospital team

• C2 Curated resources for you

• A1 Learn more about its compact packaging and bleed control.
• A2 Learn more about its compact packaging and bleed control.
• B1 Learn more about this fast and effective rFVIIa therapy.
• B2 Learn more about this fast and effective rFVIIa therapy.
• C1 This rFVIIa therapy contributes to hospital pharmacy efficiency.
• C2 This rFVIIa therapy contributes to hospital pharmacy efficiency

Handoff: September 2022

(Updated GA tagging to new HCP format)

• n7-hsp-btbs-patients
• n7-hsp-btbs-patients.html
• US22NSVN00069   November 2022

• Last updated: 2022-12-13 14:08:13

• Version: 6

• HSP/HCP AUDIENCE:
• A1: Recommendations for treatment of certain breakthrough bleeds
• A2: Certain breakthrough bleeds in your patients? Recommendations for treatment
• B1: Why you should treat certain breakthrough bleeds immediately
• B2: Certain breakthrough bleeds: treating immediately is key
• PHARMACY AUDIENCE
• A1: Recommendations for equipping your pharmacy to treat certain breakthrough bleeds
• A2: Certain breakthrough bleeds in your patients? Recommendations for treatment
• B1: Why your pharmacy should be ready to treat certain breakthrough bleeds
• B2: Certain breakthrough bleeds: is your pharmacy ready to treat them?
• [Hospital Phrasee Subject Lines:]
• 1: Are your patients experiencing breakthrough bleeds? Explore these treatment recommendations
• 2: If you need guidance on dealing with your patients' breakthrough bleeds, look here 👀
• 3: We think THIS treatment info might interest you...
• 4: 👋 You might appreciate this - view suggestions for treating breakthrough bleeds
• 5: For your patients with bleeding disorders: they could benefit from this
• 6: ** Stay updated on their treatment options **
• 7: You could be better prepared for your patients' breakthrough bleeds (see how!)
• [Pharmacy Phrasee Subject Lines:]
• 1: A message for you: are you prepared to treat breakthrough bleeds?
• 2: ↪ Make sure you're prepared...
• 3: Treating breakthrough bleeds - here's some useful information
• 4: Want to make sure you're ready to treat breakthrough bleeds?
• 5: Breakthrough bleeds: recommendations for your pharmacy inside
• 6: Treatment recommendations you might be interested in 👉
• 7: Your update: does your pharmacy have EVERYTHING it needs to treat breakthrough bleeds?
• 8: ** For your pharmacy ** Do you have everything you need?
• 9: Here are some recommendations for your pharmacy...

• HSP/HCP AUDIENCE
• A2: See why an additional treatment can help.
• A2: See why an additional treatment can help.
• B1: See MASAC recommendations.
• B2: See MASAC recommendations.
• PHARMACY AUDIENCE
• A1: See why an additional treatment can help.
• A2: See why an additional treatment can help.
• B1: Discover a MASAC recommended treatment.
• B1: Discover a MASAC recommended treatment.

Handoff: November 2022

(Updated GA tagging to new HCP format)

• n7-hcp-gt-journey-diagnose
• n7-hcp-gt-journey-diagnose.html
• US22NSVN00061   October 2022

• Last updated: 2022-11-21 08:55:54

• Version: 12

• A1 (Name:) Targeted tools and education for you

• A2 Glanzmann's Thrombasthenia tools and education

• B1 A diagnostic algorithm for Glanzmann's Thrombasthenia (GT)

• B2 (Name:) Try the Glanzmann's Thrombasthenia (GT) diagnostic algorithm

• A1 Tools to help you diagnose Glanzmann's thrombasthenia.
• A2 Tools to help you diagnose Glanzmann's thrombasthenia.
• B1 Could it be GT? Use these resources to learn more about GT diagnosis.
• B2 Could it be GT? Use these resources to learn more about GT diagnosis.

Handoff: October 2022

• n7-hcp-gt-journey-support
• n7-hcp-gt-journey-support.html
• US22NSVN00066   October 2022

• Last updated: 2022-11-21 17:21:39

• Version: 7

• A1 Prescribing this rFVIIa treatment?

• A2 Try tools to help you calculate a dose for this rFVIIa treatment on novoMEDLINK™

• B1 Easily calculate dosing for this rFVIIa treatment

• B2 Have you prescribed this rFVIIa treatment?

• PHRASEE SUBJECT LINES

• 1 🔎 Find useful information for healthcare providers and patients 🔎

• 2 You may find these rFVIIa treatment tools useful!

• 3 Hello 👋 Want to learn more about this rFVIIa treatment?

• 4 Do you have questions about prescribing or dosing for this rFVIIa treatment?

• 5 Educational materials available | Here's what you should know about this rFVIIa treatment

• 6 ** This info is for YOU **

• 7 See why it may be time to think about prescribing this rFVIIa treatment (and get access to helpful information)

• 8 Have you thought about this rFVIIa treatment for your patients?

• A1 Discover quick ordering options that fit your busy schedule.
• A2 Discover quick ordering options that fit your busy schedule.
• B1 We have resources to help you treat this bleeding disorder.
• B2 We have resources to help you treat this bleeding disorder.

Handoff: October 2022

• n7-studied-with-hemlibra
• n7-studied-with-hemlibra.html
• US20NSVN00069   November 2020

• Last updated: 2022-11-10 18:22:06

• Version: 7

• A1 The research behind this recombinant therapy may help your patients

• A2 Your patients can rely on the research behind this factor therapy

• B1 This factor therapy offers proven safety for patients with acute bleeds

• B2 Your patients with acute bleeds can rely on these proven safety results

• A1 See the clinical data and safety profile.
• A2 Explore the established bleed control and safety profile.
• B1 See the clinical data behind this recombinant treatment.
• B2 Explore the established bleed control and safety profile.

Handoff: November 2020

(Updated GA tagging for Re-Deployment)

• n7-hcp-gt-journey-efficacy-safety
• n7-hcp-gt-journey-efficacy-safety.html
• US22NSVN00063   October 2022

• Last updated: 2022-10-28 17:42:54

• Version: 9

• A1 Explore safety and efficacy data on this rFVIIa option for Glanzmann's thrombasthenia

• A2 Learn more about a treatment option for Glanzmann's thrombasthenia

• B1 Considering treatments for your Glanzmann's thrombasthenia (GT) patients?

• B2 Are you prepared to treat Glanzmann's thrombasthenia (GT) patients?

• A1 Data and resources curated for you.
• A2 Data and resources curated for you.
• B1 Learn more about this treatment option for GT patients.
• B2 Learn more about this treatment option for GT patients.

Handoff: October 2022

• n7-global-campaign-healthcare-professional-series (Healthcare Professional Version)
• n7-global-campaign-healthcare-professional-series.html
• US22NSVN00037   September 2022

• Last updated: 2022-09-22 18:43:00

• Version: 6

• A1 30+ years of effective bleed control

• A2 Trusted bleed control with established experience

• B1 Trusted bleed control for a range of rare bleeding disorders

• B2 A recombinant treatment for a wide range of rare bleeding disorders

• A1 See why patients and professionals use this rFVIIa treatment.
• A2 See why patients and professionals use this rFVIIa treatment.
• B1 Explore the data for this rFVIIa therapy.
• B2 Explore the data for this rFVIIa therapy.

Handoff: September 2022

• n7-hcp-gt-journey-gt-vs-vwd
• n7-hcp-gt-journey-gt-vs-vwd.html
• US22NSVN00062   October 2022

• Last updated: 2022-10-28 17:42:54

• Version: 9

• A1 (Name:) Can you spot the differences between these rare bleeding disorders?

• A2 Can you spot the differences between Glanzmann's Thrombasthenia and von Willebrand's?

• B2 (Name:) Tools to help avoid misdiagnosing this rare bleeding disorder

• A1 Explore education and tools to help prevent misdiagnosis.
• A2 Explore education and tools to help prevent misdiagnosis.
• B1 Glanzmann's Thrombasthenia can be easy to miss.
• B2 Glanzmann's Thrombasthenia can be easy to miss.

Handoff: October 2022

• n7-hcp-gt-journey-identify
• n7-hcp-gt-journey-identify.html
• US22NSVN00060   October 2022

• Last updated: 2022-10-24 23:38:27

• Version: 12

• A1 (Name:) Curated educational resources for you

• A2 Tools and resources for identifying Glanzmann's Thrombasthenia

• B1 Identifying this rare bleeding disorder presents multiple challenges

• B2 (Name:) Did you know this rare bleeding disorder is often misdiagnosed?

• C1 Could one of your patients have this often misdiagnosed rare bleeding disorder?

• A1 Are you prepared to diagnose this rare bleeding disorder?
• A2 Are you prepared to diagnose this rare bleeding disorder?
• B1 Explore Glanzmann's Thrombasthenia educational resources.
• B2 Explore Glanzmann's Thrombasthenia educational resources.
• C2 Learn how to spot the signs of Glanzmann's Thrombasthenia.

Handoff: October 2022

• n7-patient-connect-with-hcl-CHES (CHES version)
• n7-patient-connect-with-hcl-CHES.html
• US21NSVN00088   January 2022

• Last updated: 2021-06-17 12:30:26

• Version: 1

• /-- PRIMARY SUBJECT LINES --/

• A1 Get the personalized support you deserve.

• A2 [NAME], have you met your HCL?

• B1 Stay connected to the bleeding disorders community.

• B2 Looking for new resources, [NAME]?

• /-- PARTNER/NO ZIP CODE AVAILABLE SUBJECT LINES --/

• A1 Get the personalized support you deserve.

• A2 Have you met your HCL?

• B1 Stay connected to the bleeding disorders community.

• B2 Looking for new resources?

• /-- PRIMARY PRE-HEADERS --/

• A1 Our team can help, [NAME].

• A2 Your Hemophilia Community Liaison is here for you.

• B1 Our team is here to support you, [NAME].

• B2 Meet your local Hemophilia Community Liaison.

• /-- PARTNER/NO ZIP CODE AVAILABLE PRE-HEADERS --/

• A1 Our team can help.

• A2 Your Hemophilia Community Liaison is here for you.

• B1 Our team is here to support you.

• B2 Meet your local Hemophilia Community Liaison.

Handoff: June 17, 2022

(Version for CHES)

• n7-hcp-sevenfact-defense-cardinal-health (Cardinal Health version)
• n7-hcp-sevenfact-defense-cardinal-health.html
• US21NSVN00105   December 2021

• Last updated: 2022-04-08 09:54:24

• Version: 1

• A1 Looking for an established treatment for your patients with bleeding disorders?

• A2 Trust comes from experience when treating patients with rare bleeding disorders

• B1 Consider prescribing an established rFVIIa for your patients

• B2 No two rFVIIa products are the same

• C1 How do these two rFVIIa products stack up?

• C2 Which rFVIIa do you prescribe for rare bleeding disorders?

• A1 See how these rFVIIa treatments stack up.
• A2 See which rFVIIa is right for your patients.
• B1 See the clinical data.
• B2 Explore the clinical data for this rFVIIa.
• C1 See which is right for your patients.
• C2 See which is right for your patients.

Handoff: April 8, 2022

(Created version for channel partner handoff for Cardinal Health)

• novomedlink-knee-bleed-video-outlook-email-b (Outlook email, Version B)
• novomedlink-knee-bleed-video-outlook-email-b.oft
• US21HRBD00240   February 2022

• Last updated: 2022-03-23 5:02:28

• Version: 1

• Engage patients with an interactive hemophilia resource

Handoff: March 23, 2022

• n7-sevenfact-defensive-messaging-la-kelley-v2
• n7-sevenfact-defensive-messaging-la-kelley-v2
• US21NSVN00090   December 2021

• Last updated: 2022-02-08 09:12:53

• Version: 2

• A1: Comparing rFVIIa treatments?

• A2: Looking for an established treatment?

• B1: Real patients, real stories

• B2: What's Miguel’s rFVIIa choice?

• C1: Only one rFVIIa has 30 years of experience and trust

• C2: Which rFVIIa comes with 30 years of experience and trust?

• D1: Choosing an rFVIIa treatment?

• D2: Get the facts about an rFVIIa treatment choice

• A1: Follow the facts.
• A2: One rFVIIa comes with 30 years of experience.
• B1: What does Miguel expect from his rFVIIa treatment?
• B2: Get the facts about an rFVIIa with 30 years of experience.
• C1: Get the facts about treatment options.
• C2: Get the facts about treatment options.
• D1: Find out why other patients choose this one.
• D2: Learn how other patients made their decision.

Handoff: 02/08/2022

(Completed some HTML QA updates. Renamed file to v2)

• n7-hcp-nml-launch-announcement
• n7-hcp-nml-launch-announcement.html
• US21NSVN00081   December 2021

• Last updated: 2021-12-16 19:21:39

• Version: 2

• A1 Explore our resources for professionals who treat certain rare bleeding disorders

• A2 All of our rare bleeding disorders content, all in one place

• A3 Multiple bleeding disorders, one place for resources

• B1 Your time is important—that’s where novoMEDLINK™ comes in

• B2 Finding resources shouldn’t take long—introducing novoMEDLINK™

• B3 One efficient place for more resources—that’s novoMEDLINK™

• A1 Take a look around the new novoMEDLINK™ experience.
• A2 Take a look around the new novoMEDLINK™ experience.
• A3 Take a look around the new novoMEDLINK™ experience.
• B1 Find treatment info for your patients with certain rare bleeding disorders.
• B2 Find treatment info for your patients with certain rare bleeding disorders.
• B3 Find treatment info for your patients with certain rare bleeding disorders.

Handoff: December 2021

• n7-hsp-nml-launch-announcement
• n7-hsp-nml-launch-announcement.html
• US21NSVN00081   December 2021

• Last updated: 2021-12-15 20:46:53

• Version: 1

• A1 Explore our resources for professionals who treat certain rare bleeding disorders

• A2 All of our rare bleeding disorders content, all in one place

• A3 Multiple bleeding disorders, one place for resources

• B1 Your time is important—that’s where novoMEDLINK™ comes in

• B2 Finding resources shouldn’t take long—introducing novoMEDLINK™

• B3 One efficient place for more resources—that’s novoMEDLINK™

• A1 Take a look around the new novoMEDLINK™ experience.
• A2 Take a look around the new novoMEDLINK™ experience.
• A3 Take a look around the new novoMEDLINK™ experience.
• B1 Find treatment info for your patients with certain rare bleeding disorders.
• B2 Find treatment info for your patients with certain rare bleeding disorders.
• B3 Find treatment info for your patients with certain rare bleeding disorders.

Handoff: December 2021

• novomedlink-knee-bleed-video-outlook-email-a (Outlook email)
• novomedlink-knee-bleed-video-outlook-email-a.oft
• US21HRBD00226   November 2021

• Last updated: 2021-11-18 11:29:28

• Version: 1

• Educate patients on the need to treat joint bleeds quickly

Handoff: November 18, 2021

• n7-hcp-urgency-to-treat
• n7-hcp-urgency-to-treat.html
• US21NSVN00065   October 2021
• Email on Acid

• Last updated: 2021-10-05 21:52:40

• Version: 6

• HCPs-A1 For acute bleeds, treating early is critical

• HCPs-A2 Your first choice for breakthrough bleeds

• HCPs-A3 For acute bleeds, don’t watch and wait

• Nurses-A1 When your patients have an acute bleed, treat immediately

• [object Object]

• Nurses-A3 Support patients with acute bleeds

• HCPs-A1 See what MASAC recommends.
• HCPs-A2 See the data.
• HCPs-A3 See what MASAC recommends.
• Nurses-A1 See what MASAC recommends.
• Nurses-A2 Support your patients.
• Nurses-A3 Don’t watch and wait.

Handoff: October 2021

• n7-patient-established-experienced-effective-la-kelley (Version for LA Kelley)
• n7-patient-established-experienced-effective-la-kelley.html
• US20NSVN00025   March 2020

• Last updated: 2021-08-20 13:12:43

• Version: 2

• 3 reasons why this recombinant therapy may be the right choice for you

• 3 reasons to consider this recombinant therapy for hemophilia with inhibitors

• 3 reasons to consider this recombinant therapy for GT with resistance to platelets

• 3 reasons to consider this recombinant therapy for Factor VII deficiency

• Established, Experienced, Effective: This recombinant therapy is all 3

• An established, experienced, and effective therapy for hemophilia with inhibitors

• An established, experienced, and effective therapy for GT with resistance to platelets

• An established, experienced, and effective therapy for Factor VII deficiency

• More about our commitment to your treatment journey.
• Explore the dedication behind this treatment option.

Handoff: August 20, 2021

(Updated GA tags)

• n7-hsp-sevenfact-competitive-rm-PDQ
• n7-hsp-sevenfact-competitive-rm-PDQ.html
• US20NSVN00115   February 2021

• Last updated: 2021-06-02 10:12:43

• Version: 1

• C1 Is your hospital prepared for bleeds in CHwI patients under age 12?

• C2 Is your ED team prepared for bleeds in CHwI patients under age 12?

• D1 Prepare your staff to treat the most severe bleeds in CHwI patients

• D2 Prepare your staff to treat the most severe bleeds in CHwI patients

• C1 Learn which bypassing agent is indicated for all ages.
• C2 Learn which bypassing agent is indicated for all ages.
• D1 Choose a bypassing agent that is proven in these patients.
• D2 Choose a bypassing agent with proven efficacy.

Handoff: June 2021

• n7-patient-be-the-face-CHES
• n7-patient-be-the-face-CHES.html
• US21NSVN00001   February 2021

• Last updated: 2021-04-08 12:23:18

• Version: 1

• 
  
  emoji codes:
  📸 U+1F4F8
  📣 U+1F4E3

• A1 📸 Your story should take center stage

• A2 📸 Shining the spotlight on your story

• B1 📣 Here’s your chance to “Be the Face” of the bleeding disorders community

• B2 📣 Here’s an exciting opportunity to “Be the Face” for those with a bleeding disorder

• A1 See how to share your experience with the community.
• A2 Ready to inspire others with your experience?
• B1 Inspire others by sharing your story.
• B2 Learn how you could inspire the community.

Handoff: April 08, 2021

• n7-consumer-council-follow-up-outlook
• n7-consumer-council-follow-up-outlook.html
• US20NSVN00062   October 2020
•  
•  

Handoff: April 05, 2021

• n7-consumer-council-thank-you-outlook
• n7-consumer-council-thank-you-outlook.html
• US20NSVN00061   June 2020
•  
•  

Handoff:  

• n7-hsp-sevenfact-competitive-rm-asd
• n7-hsp-sevenfact-competitive-rm-asd.html
• US20NSVN00115   February 2021

• Last updated: 2021-03-08 19:20:55

• Version: 1

• C1 Is your hospital prepared for bleeds in CHwI patients under age 12?

• C2 Is your ED team prepared for bleeds in CHwI patients under age 12?

• D1 Prepare your staff to treat the most severe bleeds in CHwI patients

• D2 Prepare your staff to treat the most severe bleeds in CHwI patients

• C1 Learn which bypassing agent is indicated for all ages.
• C2 Learn which bypassing agent is indicated for all ages.
• D1 Choose a bypassing agent that is proven in these patients.
• D2 Choose a bypassing agent with proven efficacy.

Handoff: February 2021

• n7-hsp-sevenfact-competitive-rm-mckesson
• n7-hsp-sevenfact-competitive-rm-mckesson.html
• US20NSVN00115   February 2021

• Last updated: 2021-03-03 21:41:33

• Version: 4

• Is your ED ready for CHwI patients of all ages?

• Treating CHwI in the ED: Trials and efficacy

• With CHwI, emergent bleeds need informed decisions

Handoff: February 2021

• n7-hsp-sevenfact-competitive-rm
• n7-hsp-sevenfact-competitive-rm.html
• US20NSVN00115   February 2021

• Last updated: 2022-05-25 10:12:43

• Version: 6

• C1 Is your hospital prepared for bleeds in CHwI patients under age 12?

• C2 Is your ED team prepared for bleeds in CHwI patients under age 12?

• D1 Prepare your staff to treat the most severe bleeds in CHwI patients

• D2 Prepare your staff to treat the most severe bleeds in CHwI patients

• C1 Learn which bypassing agent is indicated for all ages.
• C2 Learn which bypassing agent is indicated for all ages.
• D1 Choose a bypassing agent that is proven in these patients.
• D2 Choose a bypassing agent with proven efficacy.

Handoff: May 2022

• n7-hcp-sevenfact-competitive-rm
• n7-hcp-sevenfact-competitive-rm.html
• US20NSVN00115   February 2021

• Last updated: 2021-04-30 10:12:43

• Version: 7

• A1 How do you treat bleeds in CHwI patients under age 12?

• A2 When choosing a bypassing agent, think about range

• B1 How do you treat bleeds in pediatric CHwI patients?

• B2 When choosing a bypassing agent, think about range

• A1 Know which bypassing agent is indicated for all ages.
• A2 Learn which agent treats a broad range of patients.
• B1 Learn which bypassing agent is indicated for all ages.
• B2 Learn which agent has the most indications in rare bleeding disorders.

Handoff: February 2021

• n7-pt-be-the-face-outlook
• n7-pt-be-the-face-outlook.html
• US21NSVN00008   February 2021

• Last updated: 2021-02-18 13:11:18

• Version: 3

• A: Your story may help others with a bleeding disorder feel less alone

• B: I think your inspiring experience will help the bleeding disorders community

• C: Your story is powerful, and I know it will inspire others.

• D: It was so great to talk to you and hear your story

• E: Here’s more info about the “Be the Face” campaign I mentioned

• F: Following up from our introduction with an exciting opportunity!

• H: I’ve always thought you had a powerful story that should be shared

• I: Your story is perfect for the “Be the Face” campaign I mentioned

• J: Sharing your experience could really inspire others

• N/A

Handoff: February 2021

• n7-patient-be-the-face-la-kelley
• n7-patient-be-the-face-la-kelley.html
• US21NSVN00001   February 2021
• email on acid

• Last updated: 2021-03-09 19:33:18

• Version: 1

• 
  
  emoji codes:
  📸 U+1F4F8
  📣 U+1F4E3

• A1 📸 Your story should take center stage

• A2 📸 Shining the spotlight on your story

• B1 📣 Here’s your chance to “Be the Face” of the bleeding disorders community

• B2 📣 Here’s an exciting opportunity to “Be the Face” for those with a bleeding disorder

• A1 See how to share your experience with the community.
• A2 Ready to inspire others with your experience?
• B1 Inspire others by sharing your story.
• B2 Learn how you could inspire the community.

Handoff: March 2021

• n7-patient-be-the-face
• n7-patient-be-the-face.html
• US21NSVN00001   February 2021
• email on acid

• Last updated: 2021-02-11 19:33:18

• Version: 2

• 
  
  emoji codes:
  📸 U+1F4F8
  📣 U+1F4E3

• A1 📸 Your story should take center stage

• A2 📸 Shining the spotlight on your story

• B1 📣 Here’s your chance to “Be the Face” of the bleeding disorders community

• B2 📣 Here’s an exciting opportunity to “Be the Face” for those with a bleeding disorder

• A1 See how to share your experience with the community.
• A2 Ready to inspire others with your experience?
• B1 Inspire others by sharing your story.
• B2 Learn how you could inspire the community.

Handoff: February 2021

• N7-PT-GT-2-TalkingtoYourDoctor-CHES
• N7-PT-GT-2-TalkingtoYourDoctor-CHES.html
• US19NSVN00139   October 2020

• Last updated: 2020-12-22 11:43:00

• Version: 2

• A1 What GT treatment questions should you ask your doctor?

• A2 Make the most of your next doctor’s appointment

• B1 Is your treatment for Glanzmann’s thrombasthenia doing the job?

• B2 A doctor discussion guide specific to Glanzmann’s thrombasthenia

• A1 Our discussion guide for Glanzmann’s thrombasthenia can help.
• A2 Download our discussion guide for Glanzmann’s thrombasthenia.
• B1 If you haven’t taken this quiz, you may be missing answers.
• B2 Download the guide to make the most of your next visit

Handoff: December 2020

• n7-hcp-standard-of-care
• n7-hcp-standard-of-care.html
• US20NSVN00114   December 2020
• Email on Acid

• Last updated: 2020-12-11 19:17:06

• Version: 4

• A1 Which bypassing agent do providers choose for breakthrough bleeds?

• A2 Refine your standard of care for CHAwI patients on emicizumab

• B1 Which bypassing agent do providers choose for breakthrough bleeds?

• B2 Refine your standard of care for breakthrough bleeds

• A1 Review what clinical trials show about usage with emicizumab.
• A2 Know the safety and dosing information for treating bleeds.
• B1 Review the safety data for your patients.
• B2 Know the safety and dosing information for different treatment options.

Handoff: December 2020

• n7-hsp-htm-sevenfact
• n7-hsp-htm-sevenfact.html
• US20NSVN00158   November 2020
• Email on Acid

• Last updated: 2020-12-01 01:17:12

• Version: 4

• A: Meeting request: Consider the benefits of this recombinant factor therapy

• B: Let’s discuss the key benefits of this recombinant factor therapy

• C: Let’s talk about how this recombinant factor therapy can support your patients

• D: Meeting request: How could this recombinant factor therapy support your patients?

Handoff: November 2020

• n7-hsp-hiam-sevenfact
• n7-hsp-hiam-sevenfact.html
• US20NSVN00116   November 2020
• Email on Acid

• Last updated: 2020-12-04 15:11:20

• Version: 2

• A: Meeting request: Consider the features of this recombinant factor therapy

• B: Which recombinant factor therapy do you keep on hand for patients?

• C: Let’s talk about updated discounts for this recombinant factor therapy

• D: Meeting request: How could this recombinant factor therapy support your patients?

• E: Get additional discounts on this recombinant factor therapy

• F: Let me know if you have questions about ordering this recombinant factor therapy